Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ASND
ASND News & Events
-
Add to Watchlist
Trade ASND Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ASND News
Siren Fully Liquidates Ascendis Pharma Holdings
May 14 2026
Fool
Ascendis Pharma to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Ascendis Pharma Announces Redemption of Convertible Notes
Apr 21 2026
Newsfilter
Ascendis Pharma to Directly List Ordinary Shares on Nasdaq
Apr 12 2026
Yahoo Finance
Ascendis Pharma Plans Direct Listing on Nasdaq
Apr 08 2026
Newsfilter
Ascendis Pharma's YUVIWEL Receives FDA Orphan Drug Exclusivity
Apr 07 2026
NASDAQ.COM
RBC Capital Markets Lists 13 Biotechs Likely to Attract Takeover Interest
Mar 19 2026
seekingalpha
Ascendis Pharma Reports Positive Phase 2 Trial Results for TransCon hGH
Mar 18 2026
NASDAQ.COM
Show More News
ASND Events
No data
ASND Monitor News
Ascendis Pharma hits 5-day low amid sector rotation
May 29 2026
Ascendis Pharma announces redemption of convertible notes
Apr 22 2026
Ascendis Pharma announces direct listing on Nasdaq
Apr 09 2026
Ascendis Pharma Announces Direct Listing on Nasdaq
Apr 08 2026
Ascendis Pharma's Yuviwel Receives FDA Approval for Pediatric Use
Mar 11 2026
Ascendis Pharma's YUVIWEL Receives FDA Approval for Achondroplasia
Mar 02 2026
Ascendis Pharma Stock Falls After Crossing Below 5-Day SMA
Jan 28 2026
Ascendis Pharma hits 20-day high amid market gains
Jan 22 2026
Show More Monitor News
ASND Earnings Analysis
Ascendis Pharma A/S Posts Strong Q3 Growth- Intellectia AI™
6 months ago
Ascendis Pharma AS Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch
